GlassScriptPhysician profile
Sandeep Mehta
NPI 1124447271
$4,794.61
in general payments reported to CMS, 2019-2025
33 companies · $730 in 2025
The $730 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,111 · 2020: $455 · 2021: $698 · 2022: $1,213 · 2023: $366 · 2024: $220 · 2025: $730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,316.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,148.49 | 2019-2020 | |
| Astellas Pharma US INC | $371.62 | 2019-2025 | Myrbetriq, Xtandi |
| Antares Pharma, INC. | $308.25 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Procept Biorobotics Corporation | $279.58 | 2022-2025 | Aquabeam System |
| Boston Scientific Corporation | $254.70 | 2021-2024 | Spaceoar Vue System - 10ml, Rezum Generator |
| Endo Pharmaceuticals INC. | $240.76 | 2019-2023 | Xiaflex, Aveed |
| Pfizer INC. | $231.72 | 2019-2025 | |
| Teleflex LLC | $211.14 | 2021-2025 | Urolift |
| Merck Sharp & Dohme LLC | $163.27 | 2021-2023 | Keytruda |
| Agiliti Surgical, INC. | $160.19 | 2025 | Sonablate Hifu, Koelis Trinity Mri/US Fusion |
| Abbvie INC. | $143.53 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $123.73 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $122.09 | 2019 | |
| Progenics Pharmaceuticals, INC. | $107.84 | 2022-2023 | Pylarify |
| Edap Technomed INC | $95.78 | 2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $89.96 | 2024-2025 | Interstim, Nuro |
| Myriad Genetic Laboratories, INC. | $89.38 | 2022-2025 | Prolaris |
| Hollister Incorporated | $78.43 | 2021-2023 | Vapro Plus Pocket |
| Sumitomo Pharma America, INC. | $70.47 | 2024-2025 | Gemtesa |
| Tolmar, INC. | $70.44 | 2023-2025 | Eligard, Jatenzo |
| Ambu INC. | $68.42 | 2021-2022 | |
| Coloplast Corp | $55.19 | 2022-2025 | |
| Urovant Sciences INC | $48.07 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $42.61 | 2022 | |
| Axonics, INC. | $32.02 | 2024 | Axonics |
| Bayer Healthcare Pharmaceuticals INC. | $31.92 | 2021-2022 | |
| Olympus America INC. | $27.06 | 2025 | Soltive |
| Urogen Pharma, INC. | $26.51 | 2023 | Jelmyto |
| Verity Pharmaceuticals INC. | $23.34 | 2025 | Tlando |
| Tempus Ai, INC | $22.75 | 2024 | Xt Cdx |
| Tolmar Pharmaceuticals, INC. | $22.58 | 2021 | |
| Biotissue Holdings INC. | $21.34 | 2022 | |
| Abbott Laboratories | $11.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandeep Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.